Buffers, salts, and stabilizing chemicals are used in multi-ton quantities during pharmaceutical manufacturing. The handling of such quantities can be challenging: caking and clumping of chemicals, dust formation, and laborious weighing have a negative impact on manufacturing efficiency and may even lead to process interruptions, quality deviations, and operator safety risks. In many cases, these limitations can be overcome by granulated material. Learn the benefits of dry granulation by roller compaction as well as how granulated raw materials facilitate processability, speed up manufacturing processes, and increase operator safety.
In this webinar, you will learn:
- Which effects clumping and caking of pharmaceutical raw materials can have on operations
- How dry granulation of raw materials can help overcome these issues
- Which technical and chemical parameters are key for a suitable granulation outcome
Speaker
Thomas Briel, Ph.D.
Merck
Strategic Marketing Manager, Excipients Liquid Application
Thomas Briel is strategic marketing manager at Merck and responsible for a broad portfolio of excipients for liquid formulation. He has more than 6 years of experience in the pharma and biopharma industry with different positions in the field of pharmaceutical formulation. Thomas holds a Ph.D. in biology from the Technical University of Munich. In parallel to his Ph.D. and industry roles, Thomas acquired a B.S. in economics with a focus on marketing.
Pharma and biopharma manufacturing
- Liquid Formulation Strategies
Durata:45min
Lingua:English
Sessione 1:tenuto March 4, 2021
Per continuare a leggere, autenticati o crea un account.
Non hai un Account?